Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Volitionrx (VNRX) Change in Accured Expenses (2019 - 2025)

Historic Change in Accured Expenses for Volitionrx (VNRX) over the last 9 years, with Q3 2025 value amounting to $993076.0.

  • Volitionrx's Change in Accured Expenses rose 322072.15% to $993076.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $3568.0, marking a year-over-year decrease of 9955.19%. This contributed to the annual value of -$1.2 million for FY2024, which is 19936.88% down from last year.
  • Per Volitionrx's latest filing, its Change in Accured Expenses stood at $993076.0 for Q3 2025, which was up 322072.15% from -$560926.0 recorded in Q2 2025.
  • Volitionrx's Change in Accured Expenses' 5-year high stood at $1.2 million during Q4 2023, with a 5-year trough of -$949636.0 in Q3 2023.
  • For the 5-year period, Volitionrx's Change in Accured Expenses averaged around $99092.3, with its median value being $3345.0 (2022).
  • In the last 5 years, Volitionrx's Change in Accured Expenses plummeted by 64352.21% in 2021 and then surged by 3615156.95% in 2023.
  • Quarter analysis of 5 years shows Volitionrx's Change in Accured Expenses stood at $549403.0 in 2021, then crashed by 99.39% to $3345.0 in 2022, then surged by 36151.57% to $1.2 million in 2023, then plummeted by 166.02% to -$800624.0 in 2024, then skyrocketed by 224.04% to $993076.0 in 2025.
  • Its Change in Accured Expenses was $993076.0 in Q3 2025, compared to -$560926.0 in Q2 2025 and $372042.0 in Q1 2025.